Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Holbrook

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Bioorganic & Medicinal Chemistry Letters|September 28, 2007
The discovery of indole-derived long acting beta2-adrenoceptor agonists for the treatment of asthma and COPDAlan D Brown, Mark E Bunnage, Paul A Glossop, et al.
Clinical and Translational Science|February 23, 2021
Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19Annie Delaunois, Matthew Abernathy, Warren D Anderson, et al.
Journal of Pharmacological and Toxicological Methods|November 22, 2024
Predicting clinical outcomes from off-target receptor interactions using Secondary Intelligence™Will S Redfern, Chris E Pollard, Mark Holbrook, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinenceMark D Andrews, Paul V Fish, Julian Blagg, et al.
Regulatory Toxicology and Pharmacology : RTP|March 4, 2020
Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluationHelen Prior, Paul Baldrick, Sonja Beken, et al.
Clinical Pharmacology and Therapeutics|November 12, 2019
General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico StrategyZhihua Li, Gary R Mirams, Takashi Yoshinaga, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Bioorganic & Medicinal Chemistry Letters|September 28, 2007
The discovery of indole-derived long acting beta2-adrenoceptor agonists for the treatment of asthma and COPDAlan D Brown, Mark E Bunnage, Paul A Glossop, et al.
Clinical and Translational Science|February 23, 2021
Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19Annie Delaunois, Matthew Abernathy, Warren D Anderson, et al.
Journal of Pharmacological and Toxicological Methods|November 22, 2024
Predicting clinical outcomes from off-target receptor interactions using Secondary Intelligence™Will S Redfern, Chris E Pollard, Mark Holbrook, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinenceMark D Andrews, Paul V Fish, Julian Blagg, et al.
Regulatory Toxicology and Pharmacology : RTP|March 4, 2020
Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluationHelen Prior, Paul Baldrick, Sonja Beken, et al.
Clinical Pharmacology and Therapeutics|November 12, 2019
General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico StrategyZhihua Li, Gary R Mirams, Takashi Yoshinaga, et al.
Pageof 2